2020
DOI: 10.3122/jabfm.2020.05.200044
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Physician-Pharmacist Collaboration on Diabetes Outcomes and Health Care Use

Abstract: Objective: To evaluate the impact of physician-pharmacist collaboration for disease-state management on diabetes outcomes in primary care by comparing outcomes between physician-managed care and pharmacist collaborative care.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
22
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(24 citation statements)
references
References 25 publications
1
22
0
1
Order By: Relevance
“… 34 For example, physician-pharmacist collaboration has shown to improve blood pressure control and diabetes control. 35 , 36 , 37 In other settings, including fall prevention, enhanced multidisciplinary collaboration may have similar positive effects on patient outcomes. Yet, the effectiveness of multidisciplinary collaboration on improving patient outcomes is mostly unclear.…”
Section: Discussionmentioning
confidence: 99%
“… 34 For example, physician-pharmacist collaboration has shown to improve blood pressure control and diabetes control. 35 , 36 , 37 In other settings, including fall prevention, enhanced multidisciplinary collaboration may have similar positive effects on patient outcomes. Yet, the effectiveness of multidisciplinary collaboration on improving patient outcomes is mostly unclear.…”
Section: Discussionmentioning
confidence: 99%
“…Significant changes have been noted in the roles and responsibilities of pharmacists due to advancements in pharmaceutical services, and they are keen to adopt a critical role in managing the medication of patients, including key issues such as medication taking and adherence (Hudd, 2020;Norton et al, 2020). However, this adaptation to patient-centered pharmaceutical care can still be challenging in LMICs.…”
Section: Introductionmentioning
confidence: 99%
“…With the appearance of the patient centeredness concept and the patient‐oriented pharmaceutical care model, the pharmacist occupied a greater position in the healthcare teams globally. Such collaborative services between medical practitioners and pharmacists are envisioned to be associated with beneficial effect to the patient care, and indeed such services have become routine services in a number of countries delivered from community pharmacies, and a number of studies have documented positive impact of the collaborative care approach on patient health outcomes 11‐15 . In order to advance and extend pharmacy services to medication therapy management (MTM) or pharmaceutical care, a good relationship with physicians is needed for enhanced pharmacy services, however it is difficult to establish and requires effort 16 …”
Section: Introductionmentioning
confidence: 99%
“…Such collaborative services between medical practitioners and pharmacists are envisioned to be associated with beneficial effect to the patient care, and indeed such services have become routine services in a number of countries delivered from community pharmacies, and a number of studies have documented positive impact of the collaborative care approach on patient health outcomes. [11][12][13][14][15] In order to advance and extend pharmacy services to medication therapy management (MTM) or pharmaceutical care, a good relationship with physicians is needed for enhanced pharmacy services, however it is difficult to establish and requires effort. 16 The identification and characterisation of the range of pharmacy services provided routinely by community pharmacies and the infrastructure present in their premises can provide insights into the development of pharmacy policies and would be useful for identifying areas for further improvement that can be addressed via time-series comparisons.…”
mentioning
confidence: 99%